Socioeconomic Effects of COVID-19 on AA/B and H/L Adults with Asthma in Large Trial
Explore the socioeconomic impact of the COVID-19 pandemic on African American/Black and Hispanic/Latinx adults with asthma. The study delves into medication access, medical care quality, employment, income, bill payment, and vaccine acceptance among participants. The findings reveal varying responses and highlight the importance of addressing socioeconomic stressors and vaccine hesitancy.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
The Research Questions What are the socioeconomic effects of the COVID-19 pandemic among African American (AA/B) and Hispanic/Latinx (H/L) adults with asthma in a large trial? Impact of COVID-19 on participants Ability to get asthma medications Medical care quality Employment Income and ability to pay bills How willing are these participants to get a free COVID-19 vaccine?
Research Design and Method Study Design Sub-study of the PeRson EmPowered Asthma RElief Study (PREPARE) an open-label, multi-site, pragmatic clinical trial of inhaled corticosteroids as part of rescue therapy compared to usual care (ClinicalTrials.gov ID: NCT02995733) Population Studied: AA/B and H/L adults with moderate to severe asthma seen by primary care and specialty clinics across the US. Dataset: Monthly surveys completed by PREPARE participants from May-August 2020. Analysis Descriptive statistics for participants responses (n=321) to five COVID-19 related questions, added to their usual monthly asthma surveys in May 2020.
What the Research Found 86% (n=276) of respondents indicated that the COVID-19 outbreak had no impact on their ability to get asthma meds. However, 14% (n=45) reported that the outbreak had some impact on their ability to get their meds. Approximately 1 in 4 (n=75) indicated their medical care got worse since the beginning of the outbreak. Many respondents experienced socioeconomic stressors since the beginning of the outbreak (i.e., job loss, hours cut, put on leave, difficulty paying bills). Willingness to get a COVID-19 vaccine varied. Over 1/3 of participants indicated that they would not likely accept a COVID-19 vaccine even if free. Future studies should explore associations of socioeconomic stressors on asthma outcomes over time and seek to better understand COVID-19 vaccine receptivity in this population.
What this means for Clinical Practice African American/Black (AA/B) and Hispanic/Latinx (H/L) individuals experience greater morbidity and mortality (among AA/B) due to COVID-19,1making early and widespread vaccination particularly important for these groups. Physicians may encounter a considerable degree of vaccine hesitancy among these populations, which could further exacerbate existing disparities. Indirect consequences of the COVID-19 pandemic, such as impact on medical care for non-COVID-19 conditions and employment, can be significant factors in overall health and well-being for these populations.
